2022-2029 年全球医疗保健分析市场
市场调查报告书
商品编码
1153769

2022-2029 年全球医疗保健分析市场

Global Healthcare Analytics Market - 2022-2029

出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 约2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

预计在预测期内(2022 年至 2029 年),医疗保健分析市场规模将以 11.7% 的复合年增长率增长。

医疗保健分析会仔细检查现有的和记录在案的行业数据,以预测趋势、扩大外展范围,甚至更好地管理疾病的传播。医疗保健分析涵盖了广泛的企业领域,并提供了对宏观和微观层面的理解。探索如何提高患者护理质量、临床数据、诊断和业务管理。

市场动态

全球医疗保健分析市场的主要驱动力是对医疗保健数据分析的需求不断增长、新产品发布、慢性病患病率上升、移动技术和互联网的使用增加以及人口健康管理。对医疗保健数据分析的需求不断增长

医疗保健领域对数据分析日益增长的需求以及新产品的推出正在推动全球医疗保健分析市场的增长。

对医疗保健数据管理日益增长的需求正在推动全球医疗保健分析市场的增长。医疗行业相关的数据分析和管理,由于大量详细复杂的数据涌入,没有特定的工具是很难处理的,这是最难做的事情之一,因为你无法提取关键实现帮助你转变。为此,需要能够将海量医疗数据转化为重要信息的分析工具,改善为患者提供的医疗服务,提高医疗机构的效率。根据一项调查,超过 90% 的医疗保健组织同意数据分析对医疗保健的影响。

此外,新数据管理解决方案的开发正在推动全球医疗保健分析市场的增长。例如,2022 年 8 月,为基于价值的护理提供支持的领先人工智能平台 Apicio 将加速对集中医疗记录的实时数据访问、医疗记录和审计文件的搜索,以及基于价值的预测护理计划的加速。基于价值的护理计划。宣布推出 Apcare ChartSpace,这是一种医疗数据管理解决方案,可让临床行动洞察浮出水面。

数据安全问题和成本阻碍了全球医疗保健分析市场的增长。

但是,数据安全问题和分析解决方案的成本将阻碍全球医疗保健分析市场的增长。例如,由于黑客攻击和安全漏洞不断,数据安全风险很高,对医疗保健公司来说代价高昂,未经事先批准就披露患者数据被证明是不道德的。此外,数据分析工具和服务需要许可证和订阅,给组织带来财务负担。

COVID-19 的影响

随着大数据工具在医疗保健决策中变得越来越重要,疫情对全球医疗保健分析市场产生了积极影响。医疗保健机构、WHO 等监管机构和 NIH 已通过预测模型与大流行作斗争,以帮助分配资源、预测激增、改善患者护理和结果并采取预防措施。随着数据的不断涌入,分析这些健康数据使我们能够更理性地理解如何治疗和治疗患者。因此,大流行提高了人们对数据分析在医疗保健中重要性的认识,促进了医疗保健分析的使用,并对市场产生了积极影响。

内容

第一章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第四章市场动态

  • 市场影响因素
    • 司机
      • 医疗保健领域对数据分析的需求不断增长
      • 市场策略
    • 约束因素
      • 安全问题
      • 高许可成本
    • 商机
    • 影响分析

第五章行业分析

  • 波特的五力分析
  • 供应链分析
  • 监管分析

第 6 章 COVID-19 分析

  • COVID-19 市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章(按组件)

  • 软件
  • 硬件
  • 服务

第八章应用

  • 临床管理
  • 财务管理
  • 运营管理
  • 人口健康管理

第9章副产品

  • 描述性的
  • 预测类型
  • 说明性的

第 10 章最终用户

  • 诊所
  • 医院
  • 其他

第11章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第12章竞争格局

  • 主要发展和战略
  • 公司股票分析
  • 产品基准

第13章公司简介

  • McKesson
    • 公司简介
    • 产品组合和说明
    • 主要亮点
    • 财务摘要
  • IBM
  • OptumHealth
  • Oracle
  • Verisk Analytics
  • Centene
  • MedeAnalytics
  • Enlitic
  • Allscripts Healthcare Solutions
  • Cerner

第14章 DataM

简介目录
Product Code: DMHCIT250

Market Overview

Healthcare Analytics Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 11.7% during the forecast period (2022-2029).

Healthcare analytics scrutinizes existing and documented industry data to forecast trends, enhance outreach, and even sufficiently manage the spread of diseases. Healthcare analytics encompasses a wide spectrum of enterprises, offering to understand the macro and micro levels. It reveals ways to improve patient care quality, clinical data, diagnosis, and business management.

Market Dynamics

The major driving forces for the global healthcare analytics market are the growing need for healthcare data analysis, new product launches, the rising prevalence of chronic diseases, the increasing use of mobile technology and the internet, and the increasing demand for population health management.

The growing need for data analytics in healthcare and new product introductions is boosting the global healthcare analytics market growth.

The growing need for healthcare data management is fueling the global healthcare analytics market as far as data analytics and management concerning the healthcare industry is among the most challenging as there is a massive influx of detailed and complicated data, which makes it scary to handle in the absence of particular tools which in turn results in the disability to extract significant perception that can help in improving the healthcare service quality provided to the patients and improve the efficacy of the healthcare organization. Therefore, there is a great need for analytical tools to transform vast healthcare data into important information, which, in turn, improves the healthcare services offered to the patient and healthcare organization efficacy. As per a survey, more than 90% of healthcare organizations consented to the impact of data analytics in healthcare.

Furthermore, new data management solution development drives growth in the global healthcare analytics market. For instance, in August 2022, Apixio, a leading AI platform that powers value-based care, introduced Apicare ChartSpace, a health data management solution providing real-time data access to centralized medical charts, accelerated chart and audit file retrieval, also enabling the surfacing of probable action insights across value-based care programs.

The data security concerns and costs will hamper the global healthcare analytics market growth.

However, the analytical solutions' data security concerns and costs will hamper the growth of the global healthcare analytics market. For instance, with constant hacking and security violations, there are high data security risks, which will prove costly to healthcare companies and unethical to disclose patient data without prior authorization. Furthermore, data analytic tools and services will require licensing or subscription, creating a financial burden on the organization.

COVID-19 Impact

The pandemic positively impacted the global healthcare analytics market since big data tools have become increasingly important in healthcare decision-making. It helped healthcare providers, regulatory bodies like WHO, and NIH fight against the pandemic via predictive models to help allocate resources, predict surges, improve patient care and outcomes and employ preventive measures. As data influx was at a near-constant rate, analyzing that health data has enabled a more reasonable understanding of ways to respond to and treat patients. Thus, the pandemic has made us realize the importance of data analytics in healthcare and promoted the use of healthcare analytics, positively impacting the market.

Segment Analysis

Software solutions for healthcare analytics are expected to grow at the fastest CAGR during the forecast period (2022-2029).

Healthcare analytics software is expected to grow at the fastest CAGR during the forecast period (2022-2029) as software solutions do not require new infrastructure than existing for installation and can be easily accessed from anywhere on the device compared to the healthcare hardware analytic solution, which requires infrastructure for installation and can not be accessed from anywhere else. The construction of new infrastructure increases financial spending. Furthermore, introducing software analytics with AI has ensured the dominance of software healthcare analytical solutions over the global healthcare analytics market. For instance, in January 2020, MORE Health, a global healthcare company, introduced a new Artificial Intelligence (AI) feature on MORE Health's Physician Collaboration Platform, benefiting both the physician and patient sides of the platform. Therefore, from the mentioned data, software solutions for healthcare analytics are predicted to dominate the global market during the forecast period.

Geographical Analysis

North America holds the largest share of the global healthcare analytics market.

The North American region retains a large share of global healthcare analytics and is estimated to continue to retain it in the forecast period (2022-2029). Most of the key market players are based in the United States and have a large stake in the global healthcare analytics market through different market tactics such as collaborations, product launches, acquisitions, partnerships and many others. For instance, in October 2022, Enlitic, a leading healthcare IT company, partnered with MULTI Inc., a healthcare technology provider of authentic parts, equipment, and services. The partnership is aimed to bring the Enlitic Curie platform to healthcare providers across the U.S., helping the radiology departments drive operational improvements. Also, in December 2020, Centene, a leading multi-national healthcare enterprise, acquired Apixio, a healthcare analytics company offering Artificial Intelligence (AI) technology solutions to make sense of unstructured clinical data for its millions of members. Apixio operates independently underneath Centene's Health Care Enterprises group. Therefore, as per the data above, it is estimated that North America will dominate the global healthcare analytics market throughout the forecast period.

Competitive Landscape

The key players operating in the global healthcare analytics market are IBM, OptumHealth, Oracle, Verisk Analytics, Centene, MedeAnalytics, McKesson, Enlitic, Allscripts Healthcare Solutions, and Cerner. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of the healthcare analytics market globally. For instance, in March 2021, McKesson Corporation introduced ScriptPAS, a pharmacy management platform for oncology practices.

McKesson Corporation

Overview:

McKesson Corporation is a Texas, United States-based company founded in 1833. American company business deals with distributing pharmaceuticals and providing health information technology, medical supplies, and care management tools. McKesson Corporation delivers the third of all pharmaceuticals used in North America.

Product Portfolio:

McKesson Corporation's product portfolio for healthcare analytics has McKesson Business AnalyticsSM: Which provides actionable insights and detailed reporting necessary to help manage the business through identifying savings opportunities, correcting inefficiencies, increasing ordering compliance and building resilience in the supply chain.

The global healthcare analytics market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Need for Data Analytics in Healthcare
      • 4.1.1.2. Market Strategies
    • 4.1.2. Restraints
      • 4.1.2.1. Security Concerns
      • 4.1.2.2. High Licensing Cost
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Components

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Components
    • 7.1.2. Market Attractiveness Index, By Components
  • 7.2. Software
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Hardware
  • 7.4. Services

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Clinical Management
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Financial Management
  • 8.4. Operations Management
  • 8.5. Population Health Management

9. By Product

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.1.2. Market Attractiveness Index, By Product
  • 9.2. Descriptive
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Predictive
  • 9.4. Prescriptive

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Clinics
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Hospital
  • 10.4. Other

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. The U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. The U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Component
    • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Product Benchmarking

13. Company Profiles

  • 13.1. McKesson
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. IBM
  • 13.3. OptumHealth
  • 13.4. Oracle
  • 13.5. Verisk Analytics
  • 13.6. Centene
  • 13.7. MedeAnalytics
  • 13.8. Enlitic
  • 13.9. Allscripts Healthcare Solutions
  • 13.10. Cerner

LIST NOT EXHAUSTIVE

14. DataM

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us